FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma

FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news